Duan Da, Torosyan Hayarpi, Elnatan Daniel, McLaughlin Christopher K, Logie Jennifer, Shoichet Molly S, Agard David A, Shoichet Brian K
Department of Pharmaceutical Chemistry & Quantitative Biology Institute, University of California, San Francisco , 1700 Fourth Street, San Francisco, California 94158-2550, United States.
Howard Hughes Medical Institute and the Department of Biochemistry and Biophysics, University of California, San Francisco , San Francisco, California 94158, United States.
ACS Chem Biol. 2017 Jan 20;12(1):282-290. doi: 10.1021/acschembio.6b00791. Epub 2016 Dec 16.
Colloidal aggregates of small molecules are the most common artifact in early drug discovery, sequestering and inhibiting target proteins without specificity. Understanding their structure and mechanism has been crucial to developing tools to control for, and occasionally even exploit, these particles. Unfortunately, their polydispersity and transient stability have prevented exploration of certain elementary properties, such as how they pack. Dye-stabilized colloidal aggregates exhibit enhanced homogeneity and stability when compared to conventional colloidal aggregates, enabling investigation of some of these properties. By small-angle X-ray scattering and multiangle light scattering, pair distance distribution functions suggest that the dye-stabilized colloids are filled, not hollow, spheres. Stability of the coformulated colloids enabled investigation of their preference for binding DNA, peptides, or folded proteins, and their ability to purify one from the other. The coformulated colloids showed little ability to bind DNA. Correspondingly, the colloids preferentially sequestered protein from even a 1600-fold excess of peptides that are themselves the result of a digest of the same protein. This may reflect the avidity advantage that a protein has in a surface-to-surface interaction with the colloids. For the first time, colloids could be shown to have preferences of up to 90-fold for particular proteins over others. Loaded onto the colloids, bound enzyme could be spun down, resuspended, and released back into buffer, regaining most of its activity. Implications of these observations for colloid mechanisms and utility will be considered.
小分子的胶体聚集体是早期药物发现中最常见的假象,它们会非特异性地隔离和抑制靶蛋白。了解其结构和机制对于开发控制甚至偶尔利用这些颗粒的工具至关重要。不幸的是,它们的多分散性和短暂稳定性阻碍了对某些基本性质的探索,比如它们如何堆积。与传统胶体聚集体相比,染料稳定的胶体聚集体表现出更高的均匀性和稳定性,从而能够对其中一些性质进行研究。通过小角X射线散射和多角度光散射,对距离分布函数表明染料稳定的胶体是实心球体而非空心球体。共配制胶体的稳定性使得能够研究它们对结合DNA、肽或折叠蛋白的偏好,以及它们从彼此中纯化出一种的能力。共配制的胶体显示出几乎没有结合DNA的能力。相应地,即使存在比自身多1600倍的肽(这些肽本身是同一种蛋白消化后的产物),这些胶体仍优先隔离蛋白质。这可能反映了蛋白质在与胶体的表面到表面相互作用中所具有的亲和力优势。首次发现,胶体对特定蛋白质的偏好性可达其他蛋白质的90倍。负载在胶体上的结合酶可以通过离心沉淀、重新悬浮并释放回缓冲液中,大部分活性得以恢复。将考虑这些观察结果对胶体机制和用途的影响。